Analysis of cardiovascular risk factors and metabolic syndrome in Korean patients with psoriasis

Annals of Dermatology

Volumn 24, Issue 1, 2012, Pages 11-15

  Kim, Gun Wook ^a   Park, Hyun Je ^a   Kim, Hoon Soo ^a   Kim, Su Han ^a   Ko, Hyun Chang ^a,b   Kim, Byung Soo ^a,b   Kim, Moon Bum ^a,b   Sim, Eun Kyung ^c  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c Tongmyong University   (South Korea)

Author keywords

Cardiovascular risk; Metabolic syndrome; Psoriasis

Indexed keywords

EID: 84863174993     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2012.24.1.11     Document Type: Article

References (22)

1. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006;55:829-835. (Pubitemid 44556851)
2. Mallbris L, Ritchlin CT, Ståhle M. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep 2006;8:355-363. (Pubitemid 44638828)
3. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995;32:982-986.
4. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007;190:1-9. (Pubitemid 44908334)
5. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296:1735-1741. (Pubitemid 44547793)
6. Mallbris L, Akre O, Granath F, Yin L, Lindelöf B, Ekbom A, et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004;19:225-230. (Pubitemid 38461682)
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
8. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-3072. (Pubitemid 43113437)
9. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA 2002;288:2709-2716. (Pubitemid 35403784)
10. Molin L. Psoriasis. A study of the course and degree of severity, joint involvement, socio-medical conditions, general morbidity and influences of selection factors among previously hospitalized psoriatics. Acta Derm Venereol Suppl (Stockh) 1973;53:1-125.
11. Youn JI, Jo SJ. Clinical Study on 3, 123 Psoriatic Patients: Observation of the patients registered for the past 20 years (1982-2002) at Seoul National University Hospital Psoriasis Clinic. Korean J Dermatol 2004;42:1536-1542. (Pubitemid 40223311)
12. Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007;157:68-73. (Pubitemid 46934281)
13. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006;298:321-328.
14. Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009;145:700-703.
15. Lindegård B. Diseases associated with psoriasis in a general population of 159, 200 middle-aged, urban, native Swedes. Dermatologica 1986;172:298-304. (Pubitemid 16014779)
16. Azfar RS, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 2008;20:416-422.
17. Wakkee M, Herings RM, Nijsten T. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol 2010;130:962-967.
18. Chen YJ, Wu CY, Shen JL, Chu SY, Chen CK, Chang YT, et al. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol 2008;144:1571-1575.
19. Lim S, Lee EJ, Koo BK, Cho SI, Park KS, Jang HC, et al. Increasing trends of metabolic syndrome in Korea-based on Korean national health and nutrition examination surveys-. J Korean Diabetes Assoc 2005;29:432-439.
20. Lym YL, Hwang SW, Shim HJ, Oh EH, Chang YS, Cho BL. Prevalence and risk factors of the metabolic syndrome as defined by NCEP-ATP III. J Korean Acad Fam Med 2003;24:135-143.
21. Cohen AD, Sherf M, Vidavsky L, Vardy DA, Shapiro J, Meyerovitch J. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008;216:152-155. (Pubitemid 351158580)
22. Akhyani M, Ehsani AH, Robati RM, Robati AM. The lipid profile in psoriasis: a controlled study. J Eur Acad Dermatol Venereol 2007;21:1330-1332. (Pubitemid 350020138)